Clinical Significance of Interleukin-6, Tumor Necrosis Factor-α and High-sensitivity C-reactive Protein in Neonates with Hypoxic-ischemic Encephalopathy

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2014 Sep 5

PMID 25187835

Citations 11

Authors

Yun Shang

Lina Mu

Xixia Guo

Yuhua Li

Limin Wang

Weihong Yang

Shujun Li

Qiong Shen

Affiliations

Soon will be listed here.

Abstract

The present study aimed to investigate the potential roles of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and high-sensitivity C-reactive protein (Hs-CRP) in the progression and prognosis of neonatal hypoxic-ischemic encephalopathy (HIE). The observation group comprised 74 neonates with HIE and the control group comprised 74 healthy neonates. The serum levels of IL-6, TNF-α and Hs-CRP were measured in the patients with HIE and the normal control infants. The correlations between the variances in the levels of these inflammatory cytokines and the different clinical gradings and prognoses of the disease were analyzed. The data revealed significant upregulation of the serum levels of IL-6, TNF-α and Hs-CRP in patients with HIE. The increase in the levels of these inflammatory mediators correlated with the severity of the disease and also had a positive correlation with the prognosis of the disease. In conclusion, high levels of IL-6, TNF-α and Hs-CRP were observed in neonatal patients with HIE. Thus, these inflammatory mediators may play a role in the progression and prognosis of the disease.

Citing Articles

White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.

Tubi M, Wheeler K, Matsiyevskiy E, Hapenney M, Mack W, Chui H Neurobiol Aging. 2023; 132():1-12.

PMID: 37708739 PMC: 10843575. DOI: 10.1016/j.neurobiolaging.2023.08.002.

Therapeutic Hypothermia Modulates the Relationships Between Indicators of Severity of Neonatal Hypoxic Ischemic Encephalopathy and Serum Biomarkers.

Chavez-Valdez R, Miller S, Spahic H, Vaidya D, Parkinson C, Dietrick B Front Neurol. 2021; 12:748150.

PMID: 34795631 PMC: 8593186. DOI: 10.3389/fneur.2021.748150.

Evaluation of the role of ischemia modified albumin in neonatal hypoxic-ischemic encephalopathy.

A Talat M, Saleh R, Shehab M, Khalifa N, Sakr M, Elmesalamy W Clin Exp Pediatr. 2020; 63(8):329-334.

PMID: 32746533 PMC: 7402987. DOI: 10.3345/cep.2019.01410.

Management of Multi Organ Dysfunction in Neonatal Encephalopathy.

ODea M, Sweetman D, Bonifacio S, El-Dib M, Austin T, Molloy E Front Pediatr. 2020; 8:239.

PMID: 32500050 PMC: 7243796. DOI: 10.3389/fped.2020.00239.

Interleukins in diagnosis of perinatal asphyxia: A systematic review.

Boskabadi H, Moradi A, Zakerihamidi M Int J Reprod Biomed. 2019; 17(5).

PMID: 31435616 PMC: 6653496. DOI: 10.18502/ijrm.v17i5.4598.

References

Jacobs S, Berg M, Hunt R, Tarnow-Mordi W, Inder T, Davis P . Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013; (1):CD003311. PMC: 7003568. DOI: 10.1002/14651858.CD003311.pub3. View

Guo A, Li A, Chen X, Chen W, Sun L . [Effect of acupoint catgut embedding on motor function and serum high sensitivity C-reactive protein and IL-6 levels in patients with acute cerebral infarction]. Zhen Ci Yan Jiu. 2013; 38(3):224-8, 258. View

Oygur N, Sonmez O, Saka O, Yegin O . Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 1999; 79(3):F190-3. PMC: 1720860. DOI: 10.1136/fn.79.3.f190. View

Yousuf O, Mohanty B, Martin S, Joshi P, Blaha M, Nasir K . High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?. J Am Coll Cardiol. 2013; 62(5):397-408. DOI: 10.1016/j.jacc.2013.05.016. View

Ali C, Nicole O, Docagne F, Lesne S, MacKenzie E, Nouvelot A . Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab. 2000; 20(6):956-66. DOI: 10.1097/00004647-200006000-00008. View

Zhang P, Cheng G . [Research progress in mild hypothermia treatment of neonatal hypoxic-ischemic encephalopathy]. Zhongguo Dang Dai Er Ke Za Zhi. 2013; 15(10):918-22. View

Loddick S, Turnbull A, Rothwell N . Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1998; 18(2):176-9. DOI: 10.1097/00004647-199802000-00008. View

Silveira R, Procianoy R . Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr. 2003; 143(5):625-9. DOI: 10.1067/S0022-3476(03)00531-6. View

Chen S, Martens-Lobenhoffer J, Weissenborn K, Kielstein J, Lichtinghagen R, Deb-Chatterji M . Association of dimethylarginines and mediators of inflammation after acute ischemic stroke. J Neuroinflammation. 2012; 9:251. PMC: 3533720. DOI: 10.1186/1742-2094-9-251. View

10.

van Laerhoven H, de Haan T, Offringa M, Post B, van der Lee J . Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review. Pediatrics. 2012; 131(1):88-98. DOI: 10.1542/peds.2012-1297. View

11.

Vannucci R, Perlman J . Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1997; 100(6):1004-14. DOI: 10.1542/peds.100.6.1004. View

12.

Westberg J, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson L . Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke. 2007; 38(3):1025-30. DOI: 10.1161/01.STR.0000258113.67252.fa. View

13.

Aly H, Khashaba M, El-Ayouty M, El-Sayed O, Hasanein B . IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2005; 28(3):178-82. DOI: 10.1016/j.braindev.2005.06.006. View

14.

Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F . Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest. 2003; 33(4):352-8. DOI: 10.1046/j.1365-2362.2003.01136.x. View

15.

Windgassen E, Funtowicz L, Lunsford T, Harris L, Mulvagh S . C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med. 2011; 123(1):114-9. DOI: 10.3810/pgm.2011.01.2252. View

16.

Wang Y, Cao M, Liu A, Di W, Zhao F, Tian Y . Changes of inflammatory cytokines and neurotrophins emphasized their roles in hypoxic-ischemic brain damage. Int J Neurosci. 2012; 123(3):191-5. DOI: 10.3109/00207454.2012.744755. View

17.

Pimentel V, Gomes J, Zanini D, Abdalla F, da Costa P, Goncalves J . Evaluation of acetylcholinesterase and adenosine deaminase activities in brain and erythrocytes and proinflammatory cytokine levels in rats submitted to neonatal hypoxia-ischemia model. Mol Cell Biochem. 2013; 378(1-2):247-55. DOI: 10.1007/s11010-013-1615-9. View

18.

Bonestroo H, Nijboer C, van Velthoven C, Kavelaars A, Hack C, van Bel F . Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats. Dev Neurosci. 2013; 35(2-3):197-211. DOI: 10.1159/000346685. View

19.

Liu F, McCullough L . Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol Sin. 2013; 34(9):1121-30. PMC: 3764334. DOI: 10.1038/aps.2013.89. View

20.

Girard S, Sebire H, Brochu M, Briota S, Sarret P, Sebire G . Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav Immun. 2012; 26(8):1331-9. PMC: 5023428. DOI: 10.1016/j.bbi.2012.09.001. View